About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety and Efficacy of AIN457 in Noninfectious Uveitis

NCT00685399·23 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novartis Pharmaceuticals

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Active uveitis (i.e., uveitis that is not in remission).
Intermediate uveitis, posterior uveitis, or panuveitis must be sufficiently severe that systemic immunosuppression is indicated.

You may not be if

Active infection.
Weight must not be greater that 120kg.

The record

StatusCompleted

PhasePhase 2

Taking part76

StartedJun 2008

UpdatedJul 17, 2017

Conditions

Non-infectious Uveitis

Where23

Novartis Investigative Site
Beverly Hills, California, United States
Novartis Investigative Site
Los Angeles, California, United States
Novartis Investigative Site
Sacramento, California, United States

Clareo Health | Safety and Efficacy of AIN457 in Noninfectious Uveitis